Save the date for the 10th International Breast Surgery Workshop (IBSW) and the 6th World Consensus Conference on BIA-ALCL, scheduled for April 11-12, 2025, in Tampa, Florida,

BISA’s president Maria Gmitro and BISA’s advisor data advocate Madris Kinard of Device Events were both quoted in MedTech Dive, citing the optimism regarding Dr. Michelle Tarver’s appointment as the new Director of CDRH at FDA.

It was encouraging to see the FDA gather expert opinions along with patient advocates and advisors to create improved guidance on more patient-centered informed consent materials for potential participants considering involvement in a clinical study. BISA compiled a few takeaways after the meeting.

In her recent Guardian article, “Can Breast Implants Make You Sick?” Adrienne Matei chronicles a patient’s struggle with Breast Implant Illness (BII), highlighting the often-overlooked systemic symptoms experienced by women with breast implants.

The Plastic Surgery Foundation is currently welcoming applications for breast implant safety. The deadline to apply is December 2, 2024.

Federal health regulators are alerting doctors to stop using BioZorb Markers due to reports of serious health problems among women who had these implants placed in their breast tissue for targeted cancer treatment.

BISA wants to keep women healthy, safe, and informed. How much do YOU really know about breast implants? Test you knowledge by taking our short quiz.

With Dr. Michelle Tarver’s appointment as the new director of CDRH, BISA hopes for stronger patient-focused oversight, contrasting with past controversies.

Maria Gmitro, president of Breast Implant Safety Alliance (BISA) BISA was recently quoted in The New York Times regarding the announcement of Dr. Michelle Tarver as the new FDA CDRH Director.

Interested in who we are, what we do and why we do it? This presentation will help you understand how we want to keep women safe, healthy and informed.

The 3rd Breast Implant Health Symposium is a virtual event designed for healthcare practitioners to discuss assessing and treating patients with breast implants on November 2 and 3, 2024.

Whether it’s implants, flap reconstruction, or opting for a flat chest with aesthetic flat closure, the point is: it’s your body, your rules. But here’s the catch: some doctors didn’t seem to get the message.

BISA continues to empower women in local communities on breast cancer and breast implant safety with the 2nd "Knowledge is Beautiful" Awareness Event in Oregon.

The FDA welcomes participation during the October 30, 2024 Patient Engagement Advisory Committee (PEAC) meeting on patient-centered informed consent in clinical study of FDA-regulated medical products.

BISA wants to keep women healthy, safe, and informed. Here are 5 important things all women should know about breast implants.

In a recent podcast episode, author Mel Robbins shared her breast implant story. Many of BISA’s members can relate to her story. Can you?

In honor of Breast Cancer Awareness Month, the 2nd Annual “Knowledge is Beautiful” Awareness & Fundraiser Event is being held on Wednesday, October 16th in Bend, Oregon led by women's health advocate Sherri Gorbett.

The FDA has approved Motiva’s SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants for breast augmentation in people 22 and older.

BISA Founder Maria Gmitro and VP Sarah Beckcom attended the Women's Health Innovation Summit with over 600 attendees, 30+ investors and 3 days of phenomenal content focused on addressing the unique health needs of women.

Our collaborator, Dr. Siham Azahaf, is a breast implant illness researcher in Amsterdam, the Netherlands. She’s also a medical advisor for BISA Nonprofit and the author of many scientific papers.